Omnicell, Inc. (OMCL)
BMV
Closed
Sep 25, 2026
Day's Range
761.1652 wk Range
761.16Overview - OMCL - Omnicell, Inc.
Key Statistics
Valuation
Enterprise Value
612.70B
P/E (Trailing)
‪52.34‬
PEG Ratio
‪0.15‬
Price / Sales (TTM)
‪27.84‬
Price / Book
‪1.56‬
EV / EBITDA
‪421.34‬
Profitability
Gross Margin
‪48.98%‬
Profit Margin
‪3.13%‬
Operating Margin
‪5.90%‬
Return on Assets
‪1.52%‬
Return on Equity
‪3.05%‬
Ownership
Shares Outstanding
45.61M
Float
44.37M
Held by Insiders
‪2.14%‬
Held by Institutions
‪108.12%‬
Price stats
Beta
‪0.97‬
50-Day Avg
‪761.16‬
200-Day Avg
‪857.32‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - OMCL - Omnicell, Inc.
Peers - OMCL - Omnicell, Inc.
Peer Comparison
Compared with companies in Health Information Services listed on BMV.
Profile Summary - OMCL - Omnicell, Inc.
About
Omnicell, Inc. is a healthcare technology company that provides medication management solutions and adherence tools for hospitals, health systems, retail pharmacies, and other care settings. Omnicell’s portfolio includes automated dispensing systems, central pharmacy automation, robotic dispensing, IV compounding,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
